SCHEMBL23472391

SCHEMBL23472391

CCCCNc1ncncc1OCCCc1ccc(OC)c(OC)c1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.41
▸ CYP3A4 P08684 13/20 0.38
▸ CYP1A2 P05177 12/20 0.38
▸ CYP2C19 P33261 12/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ LMNA P02545 5/20 0.38
▸ CYP2D6 P10635 10/20 0.36
▸ TSHR P16473 8/20 0.36
▸ CYP2C9 P11712 8/20 0.36
▸ TLR7 Q9NYK1 4/20 0.36
▸ TLR8 Q9NR97 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HIF1A Q16665 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HSD17B10 Q99714 5/20 0.34
▸ CLK4 Q9HAZ1 4/20 0.34
▸ ALOX15 P16050 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23472083 0.85 SLC2A1 (0.40) SLC2A1CYP3A4CYP1A2LMNATLR7
SCHEMBL20219767 0.84 TLR7 (0.44) CYP3A4CYP1A2TLR7TLR8
SCHEMBL23472214 0.83 CYP1A2 (0.39) CYP3A4CYP1A2CYP2C19ALDH1A1LMNA
SCHEMBL20219660 0.82 TLR7 (0.49) CYP3A4CYP1A2CYP2C19ALDH1A1LMNA
SCHEMBL23472249 0.80 PDE5A (0.40) CYP3A4CYP1A2CYP2C19ALDH1A1LMNA
SCHEMBL23472141 0.79 SMN1; SMN2 (0.50) LMNATSHRMAPK1MAPTHSD17B10
SCHEMBL23472630 0.76 MAPT (0.39) CYP3A4CYP1A2ALDH1A1LMNATLR7
SCHEMBL20219424 0.76 TLR7 (0.45) CYP1A2TLR7TLR8
SCHEMBL15470097 0.75 TLR7 (0.47) CYP3A4CYP1A2CYP2D6CYP2C9TLR7
SCHEMBL20219267 0.74 TLR7 (0.44) CYP3A4CYP1A2CYP2C19ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3590928-B1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2021-06-09 — — EP disclosed
Send feedback